Performance of the SAMBA I and II HIV-1 Semi-Q Tests for viral load monitoring at the point-of-care
Neha Goel(University of Cambridge), Helen Lee(University of Cambridge), Marco Schito(Critical Path Institute), Jesse Lehga(Diagnostics for the Real World (United States)), Craig A. Wisniewski(University of Chester), Daniel Edemaga(Médecins Sans Frontières), Hiroshi Sembongi, Annemiek de Ruiter(ViiV Healthcare (Spain)), Rosario So(Diagnostics for the Real World (United States)), Tetiana Stepchenkova(Kyiv City Clinical Oncology Center), Sekesai Mtapuri‐Zinyowera(Ministry of Health and Child Welfare), Lourdes M Nadala(Diagnostics for the Real World (United States)), Clement Zeh, Laura Farleigh(University of Chester), Allyson V. Ritchie(University of Cambridge)
Cited by 34
Related Papers
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011
|AIDS|2014|397
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
|AIDS|2002|359
A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population
|Infectious Diseases and Therapy|2018|197